Citius Oncology, Inc. · NASDAQ:CTOR
Armistice Capital, LLC reported a 9.99% stake in Citius Oncology, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Armistice Capital, LLC reported a 9.99% stake in Citius Oncology, Inc., 8,078,404 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 8,078,404
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 9.99% | 8,078,404 |
| Steven Boyd | 9.99% | 8,078,404 |
Source
Related
- Citius Oncology, Inc.
- Armistice Capital, LLC
- Citius Oncology, Inc. shareholders
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2026
- Schedule 13G · Armistice Capital, LLC · Nov 14, 2025
- Schedule 13D/A · Citius Pharmaceuticals, Inc. · Jun 4, 2026
- Schedule 13D/A · Citius Pharmaceuticals, Inc. · Dec 17, 2025
- Schedule 13D/A · Citius Pharmaceuticals, Inc. · Sep 12, 2025
- Schedule 13D/A · Citius Pharmaceuticals, Inc. · Jul 25, 2025